Home Page >> Hot Issues >> Heparin Injections
Tainted Heparin Injections
[ ESPAÑOL ]
After reports that hundreds of people were experiencing allergic reactions from Heparin, Baxter Healthcare Corporation--which supplies about half of the heparin sold in the U.S.--suspended production of multi-dose vials of the blood-thinning drug. Heparin is a vital drug for about 450,000 patients currently undergoing dialysis in the US. It acts as a blood thinner by preventing the formation of clots that can trigger heart attacks or strokes. Heparin is also used in heart surgery and occasionally, patients with clotting problems have been given Heparin.
HEPARIN ARTICLES AND INTERVIEWS
Heparin Contamination Possibly More Widespread than Thought
Los Angeles, CA: Lawsuits are now being filed against Heparin's manufacturers alleging those companies are responsible for the recent Heparin contamination and subsequent illness of patients exposed to the drug. Some lawsuits have already been filed; however as more news about the contamination is released, many more people will likely realize that they, too, were a victim of Heparin and file lawsuits. [ Read More ]
More Heparin Lawsuits Filed
Boca Raton, FL: News about contaminated heparin continues to be released as more people come forward to report their experiences. Heparin-related illness affects people from many walks of life, young and old, and is not isolated to people who received Baxter-made heparin injections. [ Read More ]
Lawsuit Against Baxter and SPL alleges heparin to blame for retired nurse's injuries
Toledo, OH: Maureen and Ron Tujague of Pleasanton, California are suing Baxter Healthcare Corporation, one of the makers of contaminated heparin, and Scientific Protein Laboratories, LLC (SPL), the supplier of contaminated heparin’s active ingredient, because the contaminated heparin used by Mrs. Tujague during a dialysis treatment caused a sudden drop in blood pressure that led to heart failure, cardiac damage and a debilitating affect to her overall health. [ Read More ]
|
|
FREE CASE EVALUATION
Send your claim to a Lawyer who will review your case at NO COST or obligation.
CLICK HERE
|
| |
|
MORE HEPARIN
|
|
HEPARIN IN THE NEWS
|
JUN-27-08: A Pleasanton CA, couple are suing Baxter Healthcare Corporation, one of the companies that manufactured the tainted heparin, and Scientific Protein Laboratories LLC, because the wife has suffered debilitating affects to her health after being given the tainted heparin. [NEWS RELEASE WIRE: TAINTED HEPARIN]
|
JUN-20-08: The FDA has stated that it will have three offices open in China by the end of 2008. This move was prompted by several scandals involving tainted consumer products, and most recently, the very serious problem of tainted heparin. [FIERCE PHARMA: HEPARIN]
|
JUN-10-08: The FDA warns that devices coated with Heparin may still be available for use in some medical care facilities. [RENAL BUSINESS: HEAPRIN]
|
|
JUN-07-08: At least 30 lawsuits have been filed alleging Heparin caused harm to patients. A panel of judges has ruled that all lawsuits will be transferred to Toledo. [BLADE: HEAPRIN LAWSUITS]
|
JUN-02-08: The recent problems with Heparin show how inefficient Washington's bureaucracy can be. Eighty-one deaths have been linked to the blood thinner. [TIMES UNION: HEPARIN PROBLEMS]
|
MAY-29-08: Court records show that a company routinely shipped medical devices before safety testing or lot testing was done. This allowed heparin syringes with bacteria to be used on patients. [MY DAILY RECORD: HEPARIN TESTING]
|
|
Publish your experience here for our readers to learn from.
|
|
Heparin Deaths Reported
By February of 2008, the FDA reported four deaths and about 350 allergic reactions from Heparin. Most of the reactions were thought to be caused by high doses over a short period of time. Reactions included difficulty breathing, nausea, vomiting, excessive sweating, and rapidly falling blood pressure that could lead to life-threatening shock and death.
Adverse reactions increased after the initial recall and included Heparin lots that had not been recalled. By February 28, the FDA reported that the number of deaths had risen to 21. Baxter temporarily halted production of all Heparin products.
The FDA announced on March 21, 2008 that B. Braun Medical Inc., a supplier of Heparin in Canada, began recalling Heparin solutions as a precautionary measure. At the same time, Health Canada announced that the company's heparin products were tainted. Braun has recalled 23 lots (of 25,000 units each) that were distributed to Canada, Australia and the United States.
The FDA has now discovered that the raw ingredient in Heparin from Baxter and B. Braun came from China. It was doctored with chondroitin sulfate, a widely used, over-the-counter dietary supplement made from animal cartilage and used to treat joint pain. When chondroitin sulphate is altered, or "oversulphated," it mimics the blood-thinning action of heparin.
It isn't clear whether chondroitin sulfate was added deliberately or accidentally, but the agency does know that the doctored drug did not occur naturally or as a result of the manufacturing process.
Scientific Protein Laboratories (SPL) of Waunakee, WS has been supplying heparin to the US for 30 years and it supplied both B. Braun and Baxter heparin in its raw form. SPL moved the plant to China three years ago because the country was the biggest pig producer in the world. Ironically, a pig shortage in China due to disease may have been the precursor to the tainted drug. Changzhou SPL purchases crude heparin from brokers who buy from family farmers; allegedly, the doctoring of the drug may have been done by brokers.
The plant in Changzhou was approved by the FDA to provide heparin to the US in 2004, but the agency never inspected it. Now, the FDA is now under fire for approving Baxter's heparin without inspecting the plant. The agency has admitted that it violated its own policies by neglecting to inspect SPL's Chinese plant before approving the drug for sale in the US.
|
|
Contaminated Heparin
The House Oversight and Investigations Subcommittee has scheduled a hearing for April 15 on the distribution of contaminated heparin. As well, the committee will likely ask the FDA Commissioner how the agency will address concerns regarding its efforts to inspect foreign drug facilities.

China is now the world's largest producer of active pharmaceutical ingredients. The Government Accountability Office said that the FDA might only inspect seven percent of off-shore drug makers per year and it is estimated that the agency would need more than 13 years to inspect all the foreign drug facilities.
If you have been given Heparin and have experienced any of the above symptoms, you should see a doctor immediately.
|
Heparin Legal Help
If you or a loved one has suffered damages in this heparin contamination case, please click the link below to send your complaint to a lawyer to evaluate your claim at no cost or obligation.
Posted on Dec-27-07
Updated on Jul-3-08
|
Search 10,000 recent cases and settlements
Lawsuits:
Services:
|